Your browser doesn't support javascript.
Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?
Yamamoto, Kei; Nagashima, Mami; Yoshida, Isao; Sadamasu, Kenji; Kurokawa, Masami; Nagashima, Maki; Kinoshita, Noriko; Maeda, Kenji; Takasaki, Jin; Teruya, Katsuji; Ohmagari, Norio.
  • Yamamoto K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan. Electronic address: kyamamoto@hosp.ncgm.go.jp.
  • Nagashima M; Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, 169-0073, Japan. Electronic address: Mami_Nagashima@member.metro.tokyo.jp.
  • Yoshida I; Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, 169-0073, Japan. Electronic address: Isao_Yoshida@member.metro.tokyo.jp.
  • Sadamasu K; Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, 169-0073, Japan. Electronic address: Kenji_Sadamasu@member.metro.tokyo.jp.
  • Kurokawa M; Clinical Laboratory, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan. Electronic address: mkurokawa@hosp.ncgm.go.jp.
  • Nagashima M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan. Electronic address: mnagamatsu@hosp.ncgm.go.jp.
  • Kinoshita N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan. Electronic address: nkinoshita@hosp.ncgm.go.jp.
  • Maeda K; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, 162-0052, Japan. Electronic address: kmaeda@ri.ncgm.go.jp.
  • Takasaki J; Department of Respirology, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan. Electronic address: jtakasaki@hosp.ncgm.go.jp.
  • Teruya K; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan. Electronic address: kteruya@acc.ncgm.go.jp.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan. Electronic address: nohmagari@hosp.ncgm.go.jp.
J Infect Chemother ; 27(8): 1273-1275, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1225293
ABSTRACT
Rapid antigen tests (RATs) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have advantages over viral culture in terms of cost and rapidity of testing, but they have low sensitivity. In addition, RATs tend to be negative from approximately 11 days after symptom onset. To determine whether the antigen-negative state indicates a lack of infectiousness, we assessed the association between viral culture and RAT results. Viral culture, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and rapid antigen testing were performed on stored nasopharyngeal samples with threshold cycle values < 30, based on previous RT-qPCR testing. SARS-CoV-2 was isolated by viral culture from nine samples (45%) and one sample (17%) with positive and negative RAT results, respectively. The RAT and viral culture results were both associated with the viral load level and their cutoffs were similar, but the associations were not statistically significant. RAT might be a useful indicator of infectiousness, which can be helpful to control infection. However, further studies with larger sample size are warranted to confirm this observation.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: J Infect Chemother Journal subject: Microbiology / Drug Therapy Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: J Infect Chemother Journal subject: Microbiology / Drug Therapy Year: 2021 Document Type: Article